Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zenas BioPharma, Inc. (ZBIO)
USD27.88
-0.86 (-2.99%)
US NASDAQ Healthcare Biotechnology
Address
North Building 2451
Waltham, MA, US
Waltham, MA, US
CEO
Leon Oliver Moulder Jr.
Website
zenasbio.com
IPO
2024-09-13
CIK 1953926 ISIN US98937L1052
Description
Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. Its developmental portfolio also features ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Established in 2019, the entity was formerly recognized as Zenas BioPharma (Cayman) Limited before adopting its current name, Zenas BioPharma, Inc., in August 2023. Its headquarters are located in Waltham, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD27.88
-0.86 (-2.99%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
692.0K
Beta
-0.94
Float Shares
10.46M
Free Float %
23.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.02% | +3.43% | -5.28% | -24.51% | -44.11% | -45.11% | +119.25% | +10.91% | +10.91% | +10.91% | +10.91% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (5 ratings, all time)
Buy
Price Targets & DCF
Current price
27.88
Low
19.00
-31.9%
Consensus
33.50
+20.2%
Median
33.50
+20.2%
High
48.00
+72.2%
Ratings Trend (MoM)
88% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 7 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 5 |
39.40
+41.3%
|
| All Time | 6 |
38.67
+38.7%
|
Quality scores
Altman Z-Score
-0.16
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+100.0% ★ Q1'26: -100.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-124.5% Q1'26: -82.5% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-2,176.4%
-
EBIT margin Biotechnology: +0.0%-2,113.9%
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+7.1% Q1'26: +33.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.38× Q1'26: -0.63× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 3 EPS Ana. |
Dec 2028 6 Rev. Ana. 6 EPS Ana. |
Dec 2029 5 Rev. Ana. 4 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
5.00M
est: 15.00M (-66.7%)
|
10.00M
est: 18.00M (-44.4%)
|
9.38M
4.76M – 12.12M
-47.9% YoY
|
60.75M
21.08M – 86.83M
+547.4% YoY
|
142.14M
142.14M – 142.14M
+134.0% YoY
|
308.52M
156.47M – 398.55M
+117.1% YoY
|
509.91M
258.60M – 658.70M
+65.3% YoY
|
| EBITDA |
-163.75M
est: -5.78M (-2,734.3%)
|
-211.33M
est: -6.93M (-2,948.1%)
|
-3.61M
-4.67M – -1.83M
+47.9% YoY
|
-23.40M
-33.44M – -8.12M
-547.4% YoY
|
-54.75M
-54.75M – -54.75M
-134.0% YoY
|
-118.83M
-153.51M – -60.27M
-117.1% YoY
|
-196.40M
-253.71M – -99.61M
-65.3% YoY
|
| EBIT |
-163.89M
est: -5.79M (-2,732.5%)
|
-211.39M
est: -6.94M (-2,944.5%)
|
-3.62M
-4.68M – -1.84M
+47.9% YoY
|
-23.43M
-33.49M – -8.13M
-547.4% YoY
|
-54.83M
-54.83M – -54.83M
-134.0% YoY
|
-119.01M
-153.73M – -60.36M
-117.1% YoY
|
-196.69M
-254.08M – -99.75M
-65.3% YoY
|
| Net Income |
-156.99M
est: -303.09M (+48.2%)
|
-377.74M
est: -181.45M (-108.2%)
|
-226.49M
-262.31M – -190.66M
-24.8% YoY
|
-204.26M
-242.30M – -166.21M
+9.8% YoY
|
-160.16M
-226.57M – -93.75M
+21.6% YoY
|
-119.76M
-165.20M – -43.03M
+25.2% YoY
|
-41.60M
-57.38M – -14.95M
+65.3% YoY
|
| SGA |
29.75M
est: 47.34M (-37.2%)
|
53.32M
est: 56.81M (-6.1%)
|
29.61M
15.02M – 38.26M
-47.9% YoY
|
191.73M
66.51M – 274.04M
+547.4% YoY
|
448.61M
448.61M – 448.61M
+134.0% YoY
|
973.72M
493.83M – 1.26B
+117.1% YoY
|
1.61B
816.17M – 2.08B
+65.3% YoY
|
| EPS |
-3.76
est: -6.51 (+42.3%)
|
-8.44
est: -4.12 (-104.8%)
|
-4.83
-5.86 – -4.26
-17.1% YoY
|
-4.61
-5.42 – -3.72
+4.5% YoY
|
-3.87
-5.07 – -2.10
+15.9% YoY
|
-2.68
-3.69 – -0.96
+30.9% YoY
|
-0.93
-1.28 – -0.33
+65.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-211.72M
OE per share TTM
-4.49
Owner's Yield
-19.10%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
8.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
41
Total invested
65.14M
Insider transactions (90d)
2
Beneficial owners (>5%)
30
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SR One Capital Management, LLC | 4.91M | 12.30% | — | 4.91M | — | 4.91M | OO | — | 2024-09-23 | ↗ |
| 2 | Simeon George | 4.91M | 12.30% | — | 4.91M | — | 4.91M | IN | — | 2024-09-23 | ↗ |
| 3 | Enavate Sciences GP, LLC | 3.76M | 9.00% | — | 3.76M | — | 11.00 | OO | — | 2024-09-23 | ↗ |
| 4 | Zebra Aggregator, LP | 3.76M | 9.00% | — | 3.76M | — | 10.00 | PN | Delaware | 2024-09-23 | ↗ |
| 5 | Xencor, Inc. | 3.10M | 7.40% | 3.10M | — | 3.10M | — | CO | Delaware | 2024-10-21 | ↗ |
| 6 | Ali Behbahani | 2.61M | 6.60% | — | 2.61M | — | 2.61M | IN | Delaware | 2024-09-25 | ↗ |
| 7 | Anthony A. Florence, Jr. | 2.61M | 6.60% | — | 2.61M | — | 2.61M | IN | Delaware | 2024-09-25 | ↗ |
| 8 | Carmen Chang | 2.61M | 6.60% | — | 2.61M | — | 2.61M | IN | Delaware | 2024-09-25 | ↗ |
| 9 | Edward T. Mathers | 2.61M | 6.60% | — | 2.61M | — | 2.61M | IN | Delaware | 2024-09-25 | ↗ |
| 10 | Mohamad Makhzoumi | 2.61M | 6.60% | — | 2.61M | — | 2.61M | IN | Delaware | 2024-09-25 | ↗ |
| 11 | NEA 18 GP VGE, LLC | 2.61M | 6.60% | — | 2.61M | — | 2.61M | OO | Delaware | 2024-09-25 | ↗ |
| 12 | NEA 18 Venture Growth Equity, L.P. | 2.61M | 6.60% | — | 2.61M | — | 2.61M | PN | Delaware | 2024-09-25 | ↗ |
| 13 | NEA Partners 18 VGE, L.P. | 2.61M | 6.60% | — | 2.61M | — | 2.61M | PN | Delaware | 2024-09-25 | ↗ |
| 14 | Paul E. Walker | 2.61M | 6.60% | — | 2.61M | — | 2.61M | IN | Delaware | 2024-09-25 | ↗ |
| 15 | Rick Yang | 2.61M | 6.60% | — | 2.61M | — | 2.61M | IN | Delaware | 2024-09-25 | ↗ |
| 16 | Scott D. Sandell | 2.61M | 6.60% | — | 2.61M | — | 2.61M | IN | Delaware | 2024-09-25 | ↗ |
| 17 | Juliet Tammenoms Bakker | 2.50M | 6.00% | — | 2.50M | — | 2.50M | IN | — | 2024-09-23 | ↗ |
| 18 | Patrick G. Enright | 2.50M | 6.00% | — | 2.50M | — | 2.50M | IN | — | 2024-09-23 | ↗ |
| 19 | Abigail P. Johnson | 2.00M | 5.03% | — | — | 2.00M | — | IN | Delaware | 2024-11-12 | ↗ |
| 20 | FMR LLC | 2.00M | 5.03% | 2.00M | — | 2.00M | — | HC | Delaware | 2024-11-12 | ↗ |
| 21 | SR One Capital Fund II Aggregator, LP | 1.95M | 4.90% | — | 1.95M | — | 1.95M | PN | — | 2024-09-23 | ↗ |
| 22 | SR One Capital Partners II, LP | 1.95M | 4.90% | — | 1.95M | — | 1.95M | PN | — | 2024-09-23 | ↗ |
| 23 | AMZL, LP | 1.85M | 4.70% | — | 1.85M | — | 1.85M | PN | — | 2024-09-23 | ↗ |
| 24 | SR One Capital SMA Partners, LP | 1.85M | 4.70% | — | 1.85M | — | 1.85M | PN | — | 2024-09-23 | ↗ |
| 25 | Longitude Capital Partners IV, LLC | 1.73M | 4.10% | — | 1.73M | — | 1.73M | OO | — | 2024-09-23 | ↗ |
| 26 | Longitude Venture Partners IV, L.P. | 1.73M | 4.10% | — | 1.73M | — | 1.73M | PN | — | 2024-09-23 | ↗ |
| 27 | SR One Capital Opportunities Fund I, LP | 1.11M | 2.80% | — | 1.11M | — | 1.11M | PN | — | 2024-09-23 | ↗ |
| 28 | SR One Capital Opportunities Partners I, LP | 1.11M | 2.80% | — | 1.11M | — | 1.11M | PN | — | 2024-09-23 | ↗ |
| 29 | Longitude Prime Fund, L.P. | 774.5K | 1.90% | — | 774.5K | — | 774.5K | PN | — | 2024-09-23 | ↗ |
| 30 | Longitude Prime Partners, LLC | 774.5K | 1.90% | — | 774.5K | — | 774.5K | OO | — | 2024-09-23 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
41
-93 vs prev Q
New positions
15
Closed positions
99
Increased
29
Reduced
5
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | FMR LLC | 7.70M +2.9M (+59.8%) | 279.74M +172.7M (+161.4%) | 18.27% +6.760 pp | 0.01% +0.009 pp | USD23.51 +54.4% | 6 qtrs — |
| 2 | SR ONE CAPITAL MANAGEMENT, LP | 5.04M +126.3K (+2.6%) | 182.92M +73.9M (+67.8%) | 11.95% +0.218 pp | 25.90% +10.126 pp | USD17.41 +108.6% | 6 qtrs — |
| 3 | ENAVATE SCIENCES GP, LLC | 3.92M +157.8K (+4.2%) | 142.30M +58.8M (+70.4%) | 9.30% +0.312 pp | 28.08% +2.585 pp | USD9.32 +289.6% | 5 qtrs — |
| 4 | NEA MANAGEMENT COMPANY, LLC | 3.52M +789.5K (+28.9%) | 127.93M +67.2M (+110.8%) | 8.36% +1.827 pp | 6.52% +3.193 pp | USD21.02 +72.7% | 6 qtrs — |
| 5 | FEDERATED HERMES, INC. | 2.72M +853.7K (+45.9%) | 98.60M +57.3M (+138.6%) | 6.44% +1.994 pp | 0.16% +0.092 pp | USD21.14 +71.8% | 6 qtrs — |
| 6 | FAIRMOUNT FUNDS MANAGEMENT LLC | 2.21M +316.2K (+16.7%) | 80.21M +38.2M (+90.9%) | 5.24% +0.719 pp | 6.11% +2.325 pp | USD19.70 +84.3% | 6 qtrs — |
| 7 | NVP ASSOCIATES, LLC | 1.84M +— (+0.0%) | 66.76M +25.9M (+63.6%) | 4.36% -0.031 pp | 26.16% +1.577 pp | USD16.92 +114.6% | 6 qtrs — |
| 8 | BLACKROCK, INC. | 1.77M +538.9K (+43.9%) | 64.18M +36.9M (+135.3%) | 4.19% +1.258 pp | 0.00% +0.001 pp | USD17.89 +103.0% | 5 qtrs — |
| 9 | VANGUARD GROUP INC | 1.45M +290.3K (+25.0%) | 52.76M +26.9M (+104.4%) | 3.45% +0.669 pp | 0.00% +0.000 pp | USD16.37 +121.8% | 6 qtrs — |
| 10 | NOVO HOLDINGS A/S | 1.45M -550.0K (-27.5%) | 52.65M +8.2M (+18.6%) | 3.44% -1.338 pp | 4.09% +1.227 pp | USD12.60 +188.2% | 6 qtrs — |
| 11 | POLAR CAPITAL HOLDINGS PLC | 1.06M +1.1M (+100.0%) | 38.40M +38.4M (+100.0%) | 2.51% +2.509 pp | 0.15% +0.148 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 12 | WELLINGTON MANAGEMENT GROUP LLP | 855.3K -2.2K (-0.3%) | 31.06M +12.0M (+63.1%) | 2.03% -0.020 pp | 0.01% +0.002 pp | USD16.88 +115.1% | 6 qtrs — |
| 13 | VIVO CAPITAL, LLC | 853.5K -329.8K (-27.9%) | 30.99M +4.7M (+18.0%) | 2.02% -0.802 pp | 2.00% -0.111 pp | USD16.92 +114.6% | 6 qtrs — |
| 14 | ECOR1 CAPITAL, LLC | 789.5K +789.5K (+100.0%) | 28.67M +28.7M (+100.0%) | 1.87% +1.873 pp | 1.30% +1.301 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 15 | ARROWMARK COLORADO HOLDINGS LLC | 751.2K -73.5K (-8.9%) | 27.27M +9.0M (+49.0%) | 1.78% -0.188 pp | 0.60% +0.260 pp | USD10.45 +247.5% | 6 qtrs — |
| 16 | PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 592.0K -187.1K (-24.0%) | 21.50M +4.2M (+24.3%) | 1.40% -0.457 pp | 8.31% -1.688 pp | USD15.56 +133.4% | 6 qtrs — |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 588.4K +118.4K (+25.2%) | 21.37M +10.9M (+104.7%) | 1.40% +0.273 pp | 0.00% +0.001 pp | USD16.55 +119.4% | 6 qtrs — |
| 18 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 502.1K -78.6K (-13.5%) | 18.23M +5.3M (+41.4%) | 1.19% -0.196 pp | 0.93% +0.182 pp | USD16.92 +114.6% | 6 qtrs — |
| 19 | STATE STREET CORP | 438.3K +60.8K (+16.1%) | 15.91M +7.5M (+89.9%) | 1.04% +0.138 pp | 0.00% +0.000 pp | USD14.36 +152.9% | 5 qtrs — |
| 20 | PRICE T ROWE ASSOCIATES INC /MD/ | 369.2K -5.1K (-1.3%) | 13.41M +5.1M (+61.3%) | 0.88% -0.018 pp | 0.00% +0.001 pp | USD16.40 +121.4% | 6 qtrs — |
| 21 | POINT72 ASSET MANAGEMENT, L.P. | 368.4K +368.4K (+100.0%) | 9.21M +9.2M (+100.0%) | 0.87% +0.874 pp | 0.01% +0.010 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 213.2K +34.8K (+19.5%) | 7.74M +3.8M (+95.5%) | 0.51% +0.080 pp | 0.00% +0.001 pp | USD16.51 +119.9% | 5 qtrs — |
| 23 | BALYASNY ASSET MANAGEMENT L.P. | 193.2K +193.2K (+100.0%) | 7.01M +7.0M (+100.0%) | 0.46% +0.458 pp | 0.01% +0.009 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 24 | INVESCO LTD. | 188.0K +42.2K (+28.9%) | 6.83M +3.6M (+110.9%) | 0.45% +0.098 pp | 0.00% +0.001 pp | USD25.37 +43.1% | 2 qtrs — |
| 25 | SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 163.9K +163.9K (+100.0%) | 5.95M +5.9M (+100.0%) | 0.39% +0.389 pp | 0.02% +0.024 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 26 | NORTHERN TRUST CORP | 155.4K +22.1K (+16.6%) | 5.64M +2.7M (+90.7%) | 0.37% +0.050 pp | 0.00% +0.000 pp | USD13.43 +170.4% | 5 qtrs — |
| 27 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 133.4K +133.4K (+100.0%) | 4.85M +4.8M (+100.0%) | 0.32% +0.317 pp | 0.02% +0.017 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 28 | GOLDMAN SACHS GROUP INC | 130.7K +130.7K (+100.0%) | 4.75M +4.7M (+100.0%) | 0.31% +0.310 pp | 0.00% +0.001 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 29 | MORGAN STANLEY | 128.3K +39.6K (+44.6%) | 4.66M +2.7M (+136.6%) | 0.30% +0.093 pp | 0.00% +0.000 pp | USD17.79 +104.1% | 6 qtrs — |
| 30 | EVERSEPT PARTNERS, LP | 121.0K -37.7K (-23.8%) | 4.39M +870.0K (+24.7%) | 0.29% -0.092 pp | 0.22% -0.021 pp | USD11.38 +219.1% | 6 qtrs — |
| 31 | CAPTION MANAGEMENT, LLC | 85.7K +85.7K (+100.0%) | 3.11M +3.1M (+100.0%) | 0.20% +0.203 pp | 0.02% +0.021 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 32 | SUPERSTRING CAPITAL MANAGEMENT LP | 83.4K -13.3K (-13.8%) | 3.03M +880.6K (+41.0%) | 0.20% -0.033 pp | 1.62% -0.494 pp | USD16.92 +114.6% | 6 qtrs — |
| 33 | AQR CAPITAL MANAGEMENT LLC | 78.2K +53.6K (+218.2%) | 2.84M +2.3M (+420.4%) | 0.19% +0.127 pp | 0.00% +0.001 pp | USD27.94 +30.0% | 3 qtrs — |
| 34 | UBS GROUP AG | 69.5K +34.0K (+95.8%) | 2.52M +1.7M (+220.3%) | 0.16% +0.080 pp | 0.00% +0.000 pp | USD24.29 +49.5% | 6 qtrs — |
| 35 | BANK OF NEW YORK MELLON CORP | 51.8K +10.1K (+24.3%) | 1.88M +955.5K (+103.2%) | 0.12% +0.023 pp | 0.00% +0.000 pp | USD14.65 +147.8% | 5 qtrs — |
| 36 | SCHRODER INVESTMENT MANAGEMENT GROUP | 50.6K -62.0K (-55.0%) | 1.85M -464.2K (-20.0%) | 0.12% -0.149 pp | 0.00% 0.000 pp | USD8.19 +343.3% | 5 qtrs — |
| 37 | NUVEEN, LLC | 50.9K +30.3K (+147.8%) | 1.85M +1.4M (+305.3%) | 0.12% +0.072 pp | 0.00% +0.000 pp | USD24.85 +46.1% | 4 qtrs — |
| 38 | MILLENNIUM MANAGEMENT LLC | 49.2K -22.7K (-31.6%) | 1.79M +189.9K (+11.9%) | 0.12% -0.055 pp | 0.00% +0.000 pp | USD22.20 +63.6% | 2 qtrs — |
| 39 | BANK OF AMERICA CORP /DE/ | 47.2K +32.4K (+218.5%) | 1.71M +1.4M (+420.9%) | 0.11% +0.077 pp | 0.00% +0.000 pp | USD27.83 +30.5% | 5 qtrs — |
| 40 | IKARIAN CAPITAL, LLC | 46.8K +46.8K (+100.0%) | 1.70M +1.7M (+100.0%) | 0.11% +0.111 pp | 0.13% +0.133 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 41 | ALPS ADVISORS INC | 44.1K +24.0K (+119.9%) | 1.60M +1.2M (+259.7%) | 0.10% +0.057 pp | 0.01% +0.007 pp | USD23.52 +54.4% | 5 qtrs — |
| 42 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 36.8K +26.7K (+264.4%) | 1.34M +1.1M (+495.9%) | 0.09% +0.063 pp | 0.00% +0.000 pp | USD32.44 +11.9% | 2 qtrs — |
| 43 | — | 36.0K +36.0K (+100.0%) | 1.31M +1.3M (+100.0%) | 0.09% +0.085 pp | 0.55% +0.554 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 44 | JANE STREET GROUP, LLC | 35.8K +35.8K (+100.0%) | 1.30M +1.3M (+100.0%) | 0.08% +0.085 pp | 0.00% +0.000 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 45 | BARCLAYS PLC | 34.4K +18.9K (+121.8%) | 1.25M +986.0K (+376.0%) | 0.08% +0.045 pp | 0.00% +0.000 pp | USD25.40 +43.0% | 6 qtrs — |
| 46 | SWISS NATIONAL BANK | 31.6K +31.6K (+100.0%) | 1.15M +1.1M (+100.0%) | 0.08% +0.075 pp | 0.00% +0.001 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 47 | CITADEL ADVISORS LLC | 24.5K +24.5K (+100.0%) | 888.1K +888.1K (+100.0%) | 0.06% +0.058 pp | 0.00% +0.000 pp | USD36.31 +0.0% | 6 qtrs — |
| 48 | RHUMBLINE ADVISERS | 21.9K +732.0 (+3.5%) | 796.9K +325.9K (+69.2%) | 0.05% +0.001 pp | 0.00% +0.000 pp | USD10.64 +241.3% | 5 qtrs — |
| 49 | JPMORGAN CHASE & CO | 21.7K +15.2K (+231.8%) | 788.9K +643.5K (+442.7%) | 0.05% +0.036 pp | 0.00% +0.000 pp | USD27.86 +30.3% | 5 qtrs — |
| 50 | WELLS FARGO & COMPANY/MN | 21.2K +8.7K (+69.8%) | 768.0K +491.5K (+177.8%) | 0.05% +0.020 pp | 0.00% +0.000 pp | USD21.25 +70.9% | 5 qtrs — |
| 51 | ALLIANCEBERNSTEIN L.P. | 18.4K +— (+0.0%) | 666.3K +258.9K (+63.6%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD11.05 +228.6% | 3 qtrs — |
| 52 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 15.7K +14.6K (+1,271.3%) | 570.1K +544.7K (+2,142.8%) | 0.04% +0.035 pp | 0.00% +0.001 pp | USD34.26 +6.0% | 5 qtrs — |
| 53 | SQUAREPOINT OPS LLC | 15.5K +15.5K (+100.0%) | 564.3K +564.3K (+100.0%) | 0.04% +0.037 pp | 0.00% +0.001 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 54 | TWO SIGMA INVESTMENTS, LP | 15.1K -5.3K (-25.9%) | 548.3K +95.8K (+21.2%) | 0.04% -0.013 pp | 0.00% +0.000 pp | USD10.16 +257.4% | 6 qtrs — |
| 55 | NOMURA HOLDINGS INC | 15.0K +15.0K (+100.0%) | 544.7K +544.7K (+100.0%) | 0.04% +0.036 pp | 0.00% +0.001 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 56 | VOYA INVESTMENT MANAGEMENT LLC | 14.7K +14.7K (+100.0%) | 534.7K +534.7K (+100.0%) | 0.03% +0.035 pp | 0.00% +0.001 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 57 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 13.3K +13.3K (+100.0%) | 483.4K +483.4K (+100.0%) | 0.03% +0.032 pp | 0.04% +0.037 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 58 | LEGAL & GENERAL GROUP PLC | 13.0K +11.7K (+862.1%) | 473.0K +443.0K (+1,474.7%) | 0.03% +0.028 pp | 0.00% +0.000 pp | USD33.39 +8.7% | 5 qtrs — |
| 59 | BOOTHBAY FUND MANAGEMENT, LLC | 12.9K +12.9K (+100.0%) | 468.4K +468.4K (+100.0%) | 0.03% +0.031 pp | 0.01% +0.007 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 60 | DEUTSCHE BANK AG\ | 12.8K +554.0 (+4.5%) | 464.1K +192.6K (+71.0%) | 0.03% +0.001 pp | 0.00% +0.000 pp | USD22.50 +61.4% | 5 qtrs — |
| 61 | CREATIVE PLANNING | 12.3K +391.0 (+3.3%) | 445.6K +181.9K (+68.9%) | 0.03% +0.001 pp | 0.00% +0.000 pp | USD22.65 +60.3% | 2 qtrs — |
| 62 | XTX TOPCO LTD | 12.2K +12.2K (+100.0%) | 442.4K +442.4K (+100.0%) | 0.03% +0.029 pp | 0.01% +0.012 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 63 | LOS ANGELES CAPITAL MANAGEMENT LLC | 14.4K +14.4K (+100.0%) | 431.7K +431.7K (+100.0%) | 0.03% +0.034 pp | 0.00% +0.002 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 64 | STATE OF WISCONSIN INVESTMENT BOARD | 10.2K +10.2K (+100.0%) | 371.1K +371.1K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.001 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 65 | VOLEON CAPITAL MANAGEMENT LP | 10.2K +10.2K (+100.0%) | 369.9K +369.9K (+100.0%) | 0.02% +0.024 pp | 0.01% +0.008 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 66 | METLIFE INVESTMENT MANAGEMENT, LLC | 10.1K +— (+0.0%) | 366.7K +142.5K (+63.6%) | 0.02% 0.000 pp | 0.00% +0.001 pp | USD8.19 +343.3% | 5 qtrs — |
| 67 | TORONTO DOMINION BANK | 10.0K +10.0K (+100.0%) | 363.1K +363.1K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.001 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 68 | SCHONFELD STRATEGIC ADVISORS LLC | 9.1K +9.1K (+100.0%) | 331.4K +331.4K (+100.0%) | 0.02% +0.022 pp | 0.00% +0.002 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 69 | GSA CAPITAL PARTNERS LLP | 9.0K +9.0K (+100.0%) | 325.0K +325.0K (+100.0%) | 0.02% +0.021 pp | 0.03% +0.028 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 70 | INTECH INVESTMENT MANAGEMENT LLC | 8.9K +8.9K (+100.0%) | 321.8K +321.8K (+100.0%) | 0.02% +0.021 pp | 0.00% +0.003 pp | USD36.31 +0.0% | 4 qtrs — |
| 71 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 8.8K +1.3K (+17.7%) | 318.8K +153.2K (+92.5%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD12.40 +192.8% | 5 qtrs — |
| 72 | UBS ASSET MANAGEMENT AMERICAS INC | 8.4K +8.4K (+100.0%) | 305.0K +305.0K (+100.0%) | 0.02% +0.020 pp | 0.00% +0.000 pp | USD36.31 +0.0% | 3 qtrs — |
| 73 | JANUS HENDERSON GROUP PLC | 7.9K +7.9K (+100.0%) | 286.6K +286.6K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.000 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 74 | MARINER, LLC | 7.7K +7.7K (+100.0%) | 278.7K +278.7K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.000 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 75 | CENTIVA CAPITAL, LP | 7.5K +7.5K (+100.0%) | 272.3K +272.3K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.002 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 76 | BNP PARIBAS ARBITRAGE, SNC | 7.1K +4.0K (+126.9%) | 259.2K +189.3K (+271.1%) | 0.02% +0.009 pp | 0.00% +0.000 pp | USD27.27 +33.1% | 5 qtrs — |
| 77 | MARSHALL WACE, LLP | 7.1K +7.1K (+100.0%) | 257.8K +257.8K (+100.0%) | 0.02% +0.017 pp | 0.00% +0.000 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 78 | VIRTUS INVESTMENT ADVISERS, INC. | 6.6K +6.6K (+100.0%) | 238.0K +238.0K (+100.0%) | 0.02% +0.016 pp | 0.06% +0.065 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 79 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 6.3K +6.3K (+100.0%) | 227.2K +227.2K (+100.0%) | 0.01% +0.015 pp | 0.00% +0.000 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 80 | NEW YORK STATE COMMON RETIREMENT FUND | 6.2K +— (+0.0%) | 225.1K +87.5K (+63.6%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD7.90 +359.6% | 4 qtrs — |
| 81 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 6.2K +6.2K (+100.0%) | 224.1K +224.1K (+100.0%) | 0.01% +0.015 pp | 0.00% +0.002 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 82 | PNC FINANCIAL SERVICES GROUP, INC. | 5.8K -19.0 (-0.3%) | 211.5K +81.8K (+63.0%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD12.29 +195.4% | 6 qtrs — |
| 83 | PROSHARE ADVISORS LLC | 5.8K +5.8K (+100.0%) | 211.3K +211.3K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 84 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 4.5K +— (+0.0%) | 163.4K +63.5K (+63.6%) | 0.01% 0.000 pp | 0.00% +0.001 pp | USD8.19 +343.3% | 5 qtrs — |
| 85 | KLP KAPITALFORVALTNING AS | 3.4K +3.4K (+100.0%) | 123.5K +123.5K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.001 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 86 | STRS OHIO | 2.8K +— (+0.0%) | 101.7K +39.5K (+63.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD8.19 +343.3% | 5 qtrs — |
| 87 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 2.6K +2.6K (+100.0%) | 94.7K +94.7K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 88 | CITIGROUP INC | 2.4K +2.2K (+1,150.5%) | 85.4K +81.2K (+1,945.6%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD34.06 +6.6% | 5 qtrs — |
| 89 | CWM, LLC | 2.2K +709.0 (+48.3%) | 79.0K +46.0K (+139.4%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD17.99 +101.8% | 4 qtrs — |
| 90 | SIMPLEX TRADING, LLC | 2.0K +2.0K (+100.0%) | 71.7K +71.7K (+100.0%) | 0.00% +0.005 pp | 0.00% +0.000 pp | USD36.31 +0.0% | 1 qtrs NEW |
| 91 | AMERITAS INVESTMENT PARTNERS, INC. | 1.4K -240.0 (-14.9%) | 49.7K +14.0K (+39.1%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD8.19 +343.3% | 5 qtrs — |
| 92 | RUSSELL INVESTMENTS GROUP, LTD. | 1.3K +— (+0.0%) | 48.8K +19.0K (+63.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD22.20 +63.6% | 2 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
2
Sells
0
Shares acquired
60.0K
Shares disposed
—
Cash buys
2.00
Cash sales
—
Net activity
+60,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 35,000 | 17.62 | 616.7K | 1,786,039 | I | ↗ |
| 2026-04-28 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 18.02 | 450.5K | 1,751,039 | I | ↗ |
| 2026-03-31 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 34,000 | 19.31 | 656.5K | 1,726,039 | I | ↗ |
| 2026-03-31 | Lu Hongbo | Director | P-Purchase | A | Common Stock | 3,768 | 18.63 | 70.2K | 426,736 | I | ↗ |
| 2026-03-31 | Fairmount Funds Management LLC | Director | P-Purchase | A | Common Stock | 150,000 | 20.00 | 3.00M | 2,359,025 | I | ↗ |
| 2026-03-30 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 18.23 | 364.6K | 1,692,039 | I | ↗ |
| 2026-02-13 | Allen Patricia L | Director | P-Purchase | A | Common Stock | 4,160 | 26.36 | 109.7K | 19,860 | D | ↗ |
| 2026-02-12 | Allen Patricia L | Director | P-Purchase | A | Common Stock | 5,000 | 26.50 | 132.5K | 15,700 | D | ↗ |
| 2026-02-11 | Lu Hongbo | Director | P-Purchase | A | Common Stock | 25,985 | 22.50 | 584.7K | 347,968 | I | ↗ |
| 2026-02-02 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 57,000 | 17.96 | 1.02M | 423,155 | D | ↗ |
| 2026-01-09 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 16.55 | 331.0K | 366,155 | D | ↗ |
| 2026-01-08 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 30,000 | 16.30 | 489.0K | 346,155 | D | ↗ |
| 2026-01-07 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 16.38 | 819.0K | 316,155 | D | ↗ |
| 2025-10-09 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | P-Purchase | A | Common Stock | 63,157 | 19.00 | 1.20M | 1,917,895 | I | ↗ |
| 2025-10-09 | Nunn Jason Raleigh | Director | P-Purchase | A | Common Stock | 63,158 | 19.00 | 1.20M | 1,173,395 | I | ↗ |
| 2025-10-09 | ENRIGHT PATRICK G | Director | P-Purchase | A | Common Stock | 105,265 | 19.00 | 2.00M | 1,832,669 | I | ↗ |
| 2025-10-07 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 36,928 | 20.85 | 769.9K | 36,928 | I | ↗ |
| 2025-10-07 | Lu Hongbo | Director | P-Purchase | A | Common Stock | 263,160 | 19.00 | 5.00M | 321,983 | I | ↗ |
| 2025-10-07 | InnoCare Pharma Inc. | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 5,000,000 | D | ↗ |
| 2025-10-07 | Fairmount Funds Management LLC | Director | P-Purchase | A | Common Stock | 316,219 | 19.00 | 6.01M | 2,209,025 | I | ↗ |
| 2025-06-10 | Oliveira Orlando | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 11.94 | 1.19M | 100,000 | D | ↗ |
| 2025-06-10 | ORLOFF JOHN J | Director | A-Award | A | Stock Option (Right to Buy) | 18,500 | 11.94 | 220.9K | 18,500 | D | ↗ |
| 2025-06-10 | Nunn Jason Raleigh | Director | A-Award | A | Stock Option (Right to Buy) | 18,500 | 11.94 | 220.9K | 18,500 | D | ↗ |
| 2025-06-10 | MOULDER LEON O JR | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 400,000 | 11.94 | 4.78M | 400,000 | D | ↗ |
| 2025-06-10 | Lu Hongbo | Director | A-Award | A | Stock Option (Right to Buy) | 18,500 | 11.94 | 220.9K | 18,500 | D | ↗ |
| 2025-06-10 | Fox Jennifer A. | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 11.94 | 1.79M | 150,000 | D | ↗ |
| 2025-06-10 | Farmer Joseph L | Officer | A-Award | A | Stock Option (Right to Buy) | 175,000 | 11.94 | 2.09M | 175,000 | D | ↗ |
| 2025-06-10 | Fairmount Funds Management LLC | Director | A-Award | A | Stock Option (Right to Buy) | 18,500 | 11.94 | 220.9K | 18,500 | I | ↗ |
| 2025-06-10 | ENRIGHT PATRICK G | Director | A-Award | A | Stock Option (Right to Buy) | 18,500 | 11.94 | 220.9K | 18,500 | D | ↗ |
| 2025-06-10 | Boylan James P | Director | A-Award | A | Stock Option (Right to Buy) | 18,500 | 11.94 | 220.9K | 18,500 | D | ↗ |
| 2025-06-10 | Allen Patricia L | Director | A-Award | A | Stock Option (Right to Buy) | 18,500 | 11.94 | 220.9K | 18,500 | D | ↗ |
| 2025-04-15 | von Moltke Lisa | Officer | A-Award | A | Stock Option (Right to Buy) | 400,000 | 8.72 | 3.49M | 400,000 | D | ↗ |
| 2025-03-17 | von Moltke Lisa | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-02-18 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 6.67 | 166.8K | 266,155 | D | ↗ |
| 2025-02-07 | Xiao Ting | Director | P-Purchase | A | Common Stock | 10,000 | 7.76 | 77.6K | 10,000 | D | ↗ |
| 2024-12-16 | Oliveira Orlando | Officer | A-Award | A | Stock Option (Right to Buy) | 7,775 | 8.77 | 68.2K | 7,775 | D | ↗ |
| 2024-12-16 | Fox Jennifer A. | Officer | A-Award | A | Stock Option (Right to Buy) | 8,125 | 8.77 | 71.3K | 8,125 | D | ↗ |
| 2024-12-04 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 45,000 | 9.98 | 449.1K | 241,155 | D | ↗ |
| 2024-12-03 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 10.76 | 269.0K | 196,155 | D | ↗ |
| 2024-11-19 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 14.57 | 36.4K | 171,155 | D | ↗ |
| 2024-11-18 | MOULDER LEON O JR | Director / Officer | P-Purchase | A | Common Stock | 7,500 | 15.00 | 112.5K | 168,655 | D | ↗ |
| 2024-09-13 | Lu Hongbo | Director | P-Purchase | A | Common Stock | 58,823 | 17.00 | 1,000.0K | 58,823 | I | ↗ |
Executive team
Top executives
EBIT / Employee
-16.3K
Shares Outstanding
44.64M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Leon O. Moulder, Jr. Founder, Chief Executive Officer and Chairman | 520.0K | — | — | 3.77M | 371.8K | — | 4.66M | 80.87% | ↗ |
| 2 | 2025 | Lisa von Moltke, M.D Head of Research and Development and Chief Medical Officer | 411.7K | 5.00 | — | 2.74M | — | — | 3.50M | 78.29% | ↗ |
| 3 | 2025 | Joseph L. Farmer President and Chief Operating Officer | 520.0K | — | — | 1.65M | 336.7K | 20.8K | 2.53M | 65.27% | ↗ |
| 4 | 2024 | Leon O. Moulder, Jr. Founder, Chief Executive Officer and Chairman | 429.9K | — | — | 19.31M | 256.3K | 330.00 | 20.00M | 96.57% | ↗ |
| 5 | 2024 | Joseph L. Farmer President and Chief Operating Officer | 500.0K | — | — | 5.25M | 255.6K | 1.9K | 6.00M | 87.39% | ↗ |
| 6 | 2024 | Orlando Oliveira Chief Commercial Officer | 199.6K | 293.8K | — | 5.38M | — | 16.5K | 5.89M | 91.34% | ↗ |
| 7 | 2024 | Jennifer Fox Chief Business Officer and Chief Financial Officer | 500.0K | 100.0K | — | 3.98M | 255.6K | 421.00 | 4.84M | 82.30% | ↗ |
| 8 | 2023 | Leon O. Moulder, Jr. Founder, Chief Executive Officer and Chairman | 126.9K | — | — | 2.47M | — | — | 2.60M | 95.12% | ↗ |
| 9 | 2023 | Jennifer Fox Chief Business Officer and Chief Financial Officer | 40.1K | 450.0K | — | 2.08M | — | — | 2.57M | 80.91% | ↗ |
| 10 | 2023 | Joseph L. Farmer President and Chief Operating Officer | 471.5K | — | — | 625.0K | 197.5K | — | 1.29M | 48.30% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Leon Oliver Moulder Jr. | Founder, CEO & Chairman | 891.8K | male |
| Joseph L. Farmer | Chief Operating Officer & President | 877.5K | male |
| Jennifer A. Fox | Chief Business Officer & Chief Financial Officer | 856.0K | female |
| Lisa von Moltke | Head of Research & Development and Chief Medical Officer. | 759.6K | — |
| Orlando Oliveira | Chief Commercial Officer | 509.9K | male |
| Jeffrey Held | Chief Legal Officer | — | male |
| Heinrich Schlieker | Chief Technical Officer | — | — |
| Haley Laken | Chief Scientific Officer | — | — |
| Caroline Chevalier | Chief Administrative Officer | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ZBIO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
